bell potters no 1 biotech, page-34

GC, it really seems like you don't get it. Let's give it one more try. I'm not saying it is a yes/no decision. I'm not saying NEU won't go gangbusters and I'm not saying it will. I have NEU shares and I continue to hold in the hope of a windfall should the trial results be good (although I will likely sell in the lead up to the release as flagged by another poster). What I am talking about is the risk. You seem to suggest there is either none, or that its impossible to estimate what the risk is. I'm saying that based on the track record of biotech companies and the success rates of Phase 2 (and 3) trials, the risks are high and rather than act on the unbridled optimism/ramping of some on this forum and expect massive returns, you should only have money in NEU that you can afford to lose because there's a real chance of it failing. I can't explain it any simpler than that I'm afraid.